论文部分内容阅读
目的评估多西他赛联合卡铂同步放化疗治疗中晚期宫颈癌的近期疗效。方法回顾性分析我院收治的66例中晚期宫颈癌患者的临床资料,根据治疗方法分为两组各33例,对照组单纯放疗治疗,治疗组采用多西他赛联合卡铂同步放化疗治疗,比较两组患者近期临床疗效及不良反应发生情况。结果治疗组总有效率84.85%,高于对照组的72.73%,P<0.05;两组不良反应发生无显著性差异,P>0.05。结论采用多西他赛联合卡铂同步放化疗治疗中晚期宫颈癌,安全性高,近期疗效显著。
Objective To evaluate the short-term efficacy of docetaxel plus carboplatin in concurrent chemotherapy for advanced cervical cancer. Methods A retrospective analysis of 66 cases of advanced cervical cancer patients admitted to our hospital clinical data, divided into two groups according to the treatment of 33 patients in each group, the control group received radiotherapy alone, the treatment group with docetaxel combined carboplatin concurrent chemoradiotherapy , Comparing the two groups of patients with recent clinical efficacy and adverse reactions. Results The total effective rate of the treatment group was 84.85%, higher than that of the control group (72.73%, P <0.05). There was no significant difference between the two groups (P> 0.05). Conclusion Docetaxel and carboplatin simultaneous chemoradiotherapy for advanced cervical cancer, high safety, the recent significant effect.